What are the Future Directions in Research on MLH1 and MSH2?
Research is ongoing to better understand the complex biology of MLH1 and MSH2 and their role in cancer. Studies aim to identify additional genetic and environmental factors that influence cancer risk in individuals with MMR mutations. There is also a focus on developing new therapeutic strategies, including combination therapies that could improve outcomes for patients with MMR-deficient tumors.
